Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-26 @ 2:21 AM
Study NCT ID:
NCT04221802
Status:
COMPLETED
Last Update Posted:
2025-05-06
First Post:
2019-12-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-23
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-13
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-05
First Submit QC Date:
None
Study First Post Date:
2020-01-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-05
Last Update Post Date:
2025-05-06
Last Update Post Date Type:
ACTUAL